http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104367581-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49d82b44ab1f5dd60b490f50b9d47231 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d087da7cd835203a4509d461d99b39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55127cc2a6f3f9dffb953ac47140d575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd6f918550649558c31c760bb1966946 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_961a4c10f9ff8507339a21db5d23c0ab |
| publicationDate | 2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104367581-A |
| titleOfInvention | Application of zinc salicylate dihydrate in preparing medicine for treating breast cancer |
| abstract | The invention discloses an application of a zinc salicylate dihydrate in preparing a medicine for treating a negative breast cancer containing estrogen receptors and an administration dosage of the zinc salicylate dehydrate. The experiment proves that the zinc salicylate dihydrate is capable of inhibiting proliferation and migration of breast cancer cells so as to promote the apoptosis of the breast cancer cells in a concentration dependence manner. Thus, a novel medical application of the zinc salicylate dehydrate is explored, i.e., a novel application field is exploited. |
| priorityDate | 2014-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.